Cover Image
Market Research Report
Product code 
1044242

Market Study on Oral Macromolecular Formulations: Market to Remain Dominated by Biopharmaceutical Companies

Published: | Persistence Market Research | 158 Pages | Delivery time: 2-3 business days

Price

Back to Top
Market Study on Oral Macromolecular Formulations: Market to Remain Dominated by Biopharmaceutical Companies
Published: October 20, 2021
Persistence Market Research
Content info: 158 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Scope of the Report:

The latest publication by Persistence Market Research on the global oral macromolecular formulation market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market.

The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for oral macromolecular formulation products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the oral macromolecular formulation market.

The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the oral macromolecular formulation market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the oral macromolecular formulation market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments:

Persistence Market Research's study on the oral macromolecular formulation market offers information divided into three important segments - indication, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Indication

  • Inflammatory Bowel Disorder
  • Crohn's Disease
  • Ulcerative Colitis
  • Diabetes
  • Others

End User

  • Biopharmaceutical Companies
  • Academic and Research Institutes

Region

  • North America
  • Europe
  • Asia Pacific
  • Others

Key Questions Answered:

  • Which regions will continue to remain the most profitable markets for oral macromolecular formulations over the coming years?
  • How will changing trends impact the market?
  • How has the COVID-19 crisis impacted market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can companies in the market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the oral macromolecular formulation market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the oral macromolecular formulation market more accurate and reliable.

Product Code: PMRREP32388

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion & Exclusion

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Innovation / Development Trends
  • 3.3. Clinical pipeline assessment

4. Market Background

  • 4.1. Macro-Economic Factors
    • 4.1.1. GDP Growth Outlook
    • 4.1.2. Biopharmaceutical Outlook
    • 4.1.3. Global R&D Spending Outlook
  • 4.2. Forecast Factors - Relevance & Impact
    • 4.2.1. Rising number of biopharmaceutical companies
    • 4.2.2. Increase in R&D spending
    • 4.2.3. Advancement in Technology
    • 4.2.4. Increasing prevalence of diseases
    • 4.2.5. Increasing clinical trials
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunity Analysis

5. COVID19 Crisis Analysis

  • 5.1. Current Economic Projection as compared to 2008 financial analysis
  • 5.2. COVID19 and Impact Analysis
    • 5.2.1. Revenue by Indication
    • 5.2.2. Revenue by End User
    • 5.2.3. Revenue by Country
  • 5.3. 2020 Market Scenario

6. Key Success Factors

  • 6.1. Disease Epidemiology

7. Global Oral Macromolecular Formulation Market Value Analysis 2016-2020 and Forecast, 2021-2031

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031, by Indication

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis by Indication, 2016-2020
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2021-2031
    • 8.3.1. Inflammatory Bowel Disorder
      • 8.3.1.1. Crohn's Disease
      • 8.3.1.2. Ulcerative Colitis
    • 8.3.2. Diabetes
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis by Indication

9. Global Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2016-2020
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031
    • 9.3.1. Biopharmaceutical Companies
    • 9.3.2. Academic and Research Institutes
  • 9.4. Market Attractiveness Analysis by End User

10. Global Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031
    • 10.3.1. North America
    • 10.3.2. Europe
    • 10.3.3. Asia Pacific
    • 10.3.4. Others
  • 10.4. Market Attractiveness Analysis By Region

11. North America Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Indication
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
  • 11.5. Key Market Participants - Intensity Mapping
  • 11.6. Drivers and Restraints - Impact Analysis

12. Europe Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
    • 12.3.1. By Country
      • 12.3.1.1. Germany
      • 12.3.1.2. Italy
      • 12.3.1.3. France
      • 12.3.1.4. U.K.
      • 12.3.1.5. Russia
      • 12.3.1.6. Rest of Europe
    • 12.3.2. By Indication
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis

13. Asia Pacific Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
    • 13.3.1. By Country
      • 13.3.1.1. China
      • 13.3.1.2. Japan
      • 13.3.1.3. India
    • 13.3.2. By Indication
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis

14. Others Oral Macromolecular Formulation Market Analysis 2016-2020 and Forecast 2021-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
    • 14.3.1. By Indication
    • 14.3.2. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis

15. Key Countries Oral Macromolecular Formulation Market Analysis 2021 & 2031

  • 15.1. Introduction
    • 15.1.1. Market Value Proportion Analysis, By Key Countries
    • 15.1.2. Global Vs. Country Growth Comparison
  • 15.2. U.S. Oral Macromolecular Formulation Market Analysis
    • 15.2.1. By Indication
    • 15.2.2. By End User
  • 15.3. Canada Oral Macromolecular Formulation Market Analysis
    • 15.3.1. By Product Type
    • 15.3.2. By Indication
    • 15.3.3. By End User
  • 15.4. U.K. Oral Macromolecular Formulation Market Analysis
    • 15.4.1. By Indication
    • 15.4.2. By End User
  • 15.5. Germany Oral Macromolecular Formulation Market Analysis
    • 15.5.1. By Indication
    • 15.5.2. By End User
  • 15.6. France Oral Macromolecular Formulation Market Analysis
    • 15.6.1. By Indication
    • 15.6.2. By End User
  • 15.7. Italy Oral Macromolecular Formulation Market Analysis
    • 15.7.1. By Indication
    • 15.7.2. By End User
  • 15.8. Russia Oral Macromolecular Formulation Market Analysis
    • 15.8.1. By Indication
    • 15.8.2. By End User
  • 15.9. China Oral Macromolecular Formulation Market Analysis
    • 15.9.1. By Indication
    • 15.9.2. By End User
  • 15.10. Japan Oral Macromolecular Formulation Market Analysis
    • 15.10.1. By Indication
    • 15.10.2. By End User
  • 15.11. India Oral Macromolecular Formulation Market Analysis
    • 15.11.1. By Indication
    • 15.11.2. By End User

16. Market Structure Analysis

  • 16.1. Market Analysis by Tier of Companies
  • 16.2. Market Concentration
  • 16.3. Market Share Analysis of Top Players
  • 16.4. Market Presence Analysis
    • 16.4.1. By Regional Foot Print of Players
    • 16.4.2. Product Foot Print by Players
    • 16.4.3. Channel Foot Print by Players

17. Competition Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competition Benchmarking
  • 17.3. Competition Deep Dive
    • 17.3.1. Catalent Inc.
      • 17.3.1.1. Overview
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Analyst Commentary
      • 17.3.1.4. Key Financials
      • 17.3.1.5. Recent Developments
      • 17.3.1.6. Sales Footprint
      • 17.3.1.7. Strategy Overview
        • 17.3.1.7.1. Marketing Strategy
        • 17.3.1.7.2. Product Strategy
        • 17.3.1.7.3. Channel Strategy
    • 17.3.2. Diabetology Ltd
      • 17.3.2.1. Overview
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Analyst Commentary
      • 17.3.2.4. Key Financials
      • 17.3.2.5. Recent Developments
      • 17.3.2.6. Sales Footprint
      • 17.3.2.7. Strategy Overview
        • 17.3.2.7.1. Marketing Strategy
        • 17.3.2.7.2. Product Strategy
        • 17.3.2.7.3. Channel Strategy
    • 17.3.3. UPM Pharmaceuticals
      • 17.3.3.1. Overview
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Analyst Commentary
      • 17.3.3.4. Key Financials
      • 17.3.3.5. Recent Developments
      • 17.3.3.6. Sales Footprint
      • 17.3.3.7. Strategy Overview
        • 17.3.3.7.1. Marketing Strategy
        • 17.3.3.7.2. Product Strategy
        • 17.3.3.7.3. Channel Strategy

18. Assumptions and Acronyms Used

19. Research Methodology

List of Tables

  • Table 1: Global Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
  • Table 2: Global Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
  • Table 3: Global Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
  • Table 4: North America Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
  • Table 5: North America Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
  • Table 6: North America Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 7: Europe Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
  • Table 8: Europe Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
  • Table 9: Europe Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 10: Asia Pacific Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
  • Table 11: Asia Pacific Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
  • Table 12: Asia Pacific Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 13: Others Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
  • Table 14: Others Oral Macromolecular Formulation Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

List of Figures

  • Figure 1: Global Oral Macromolecular Formulation Market Historical Market Value (US$ Mn) Analysis, 2016-2020
  • Figure 2: Global Oral Macromolecular Formulation Current and Future Market Value (US$ Mn), 2021-2031 & Y-o-Y Growth Trend Analysis
  • Figure 3: Oral Macromolecular Formulation Market Absolute $ Opportunity, 2021-2031
  • Figure 4: Global Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 5: Global Oral Macromolecular Formulation Market Y-o-Y Growth (%) By Indication, 2021-2031
  • Figure 6: Global Oral Macromolecular Formulation Market Attractiveness Analysis, By Indication
  • Figure 7: Global Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031
  • Figure 8: Global Oral Macromolecular Formulation Market Y-o-Y Growth (%) By End User, 2021-2031
  • Figure 9: Global Oral Macromolecular Formulation Market Attractiveness Analysis, By End User
  • Figure 10: Global Oral Macromolecular Formulation Market Share Analysis (%) By Region, 2021 & 2031
  • Figure 11: Global Oral Macromolecular Formulation Market Y-o-Y Growth (%) By Region, 2021-2031
  • Figure 12: Global Oral Macromolecular Formulation Market Attractiveness Analysis, By Region
  • Figure 13: North America Oral Macromolecular Formulation Market Share, By Indication (2021)
  • Figure 14: North America Oral Macromolecular Formulation Market Share, By End User (2021)
  • Figure 15: North America Oral Macromolecular Formulation Market Share, By Country (2021)
  • Figure 16: North America Oral Macromolecular Formulation Market Value (US$ Mn) Analysis, 2016-2020
  • Figure 17: North America Oral Macromolecular Formulation Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
  • Figure 18: North America Oral Macromolecular Formulation Market Attractiveness Analysis, By Country
  • Figure 19: North America Oral Macromolecular Formulation Market Attractiveness Analysis, By Indication
  • Figure 20: North America Oral Macromolecular Formulation Market Attractiveness Analysis, By Indication
  • Figure 21: Europe Oral Macromolecular Formulation Market Share, By Indication (2021)
  • Figure 22: Europe Oral Macromolecular Formulation Market Share, By End User (2021)
  • Figure 23: Europe Oral Macromolecular Formulation Market Share, By Country (2021)
  • Figure 24: Europe Oral Macromolecular Formulation Market Value (US$ Mn) Analysis, 2016-2020
  • Figure 25: Europe Oral Macromolecular Formulation Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
  • Figure 26: Europe Oral Macromolecular Formulation Market Attractiveness Analysis, By Country
  • Figure 27: Europe Oral Macromolecular Formulation Market Attractiveness Analysis, By Indication
  • Figure 28: Europe Oral Macromolecular Formulation Market Attractiveness Analysis, By Indication
  • Figure 29: Asia Pacific Oral Macromolecular Formulation Market Share, By Indication (2021)
  • Figure 30: Asia Pacific Oral Macromolecular Formulation Market Share, By End User (2021)
  • Figure 31: Asia Pacific Oral Macromolecular Formulation Market Share, By Country (2021)
  • Figure 32: Asia Pacific Oral Macromolecular Formulation Market Value (US$ Mn) Analysis, 2016-2020
  • Figure 33: Asia Pacific Oral Macromolecular Formulation Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
  • Figure 34: Asia Pacific Oral Macromolecular Formulation Market Attractiveness Analysis, By Country
  • Figure 35: Asia Pacific Oral Macromolecular Formulation Market Attractiveness Analysis, By Indication
  • Figure 36: Asia Pacific Oral Macromolecular Formulation Market Attractiveness Analysis, By Indication
  • Figure 37: Others Oral Macromolecular Formulation Market Share, By Indication (2021)
  • Figure 38: Others Oral Macromolecular Formulation Market Share, By End User (2021)
  • Figure 39: Others Oral Macromolecular Formulation Market Value (US$ Mn) Analysis, 2016-2020
  • Figure 40: Others Oral Macromolecular Formulation Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
  • Figure 41: Others Oral Macromolecular Formulation Market Attractiveness Analysis, By Indication
  • Figure 42: Others Oral Macromolecular Formulation Market Attractiveness Analysis, By End User
  • Figure 43: U.S. Market Value Proportion Analysis
  • Figure 44: Global Vs. U.S Growth Comparison
  • Figure 45: U.S. Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 46: U.S. Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031
  • Figure 47: Canada Market Value Proportion Analysis
  • Figure 48: Global Vs. Canada Growth Comparison
  • Figure 49: Canada Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 50: Canada Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031
  • Figure 51: U.K. Market Value Proportion Analysis
  • Figure 52: Global Vs. U.K. Growth Comparison
  • Figure 53: U.K. Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 54: U.K. Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031
  • Figure 55: Germany Market Value Proportion Analysis
  • Figure 56: Global Vs. Germany Growth Comparison
  • Figure 57: Germany Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 58: Germany Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031
  • Figure 59: France Market Value Proportion Analysis
  • Figure 60: Global Vs. France Growth Comparison
  • Figure 61: France Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 62: France Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031
  • Figure 63: Italy Market Value Proportion Analysis
  • Figure 64: Global Vs. Italy Growth Comparison
  • Figure 65: Italy Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 66: Italy Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031
  • Figure 67: Russia Market Value Proportion Analysis
  • Figure 68: Global Vs. Russia Growth Comparison
  • Figure 69: Russia Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 70: Russia Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031
  • Figure 71: China Market Value Proportion Analysis
  • Figure 72: Global Vs. China Growth Comparison
  • Figure 73: China Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 74: China Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031
  • Figure 75: Japan Market Value Proportion Analysis
  • Figure 76: Global Vs. Japan Growth Comparison
  • Figure 77: Japan Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 78: Japan Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031
  • Figure 79: India Market Value Proportion Analysis
  • Figure 80: Global Vs. India Growth Comparison
  • Figure 81: India Oral Macromolecular Formulation Market Share Analysis (%) By Indication, 2021 & 2031
  • Figure 82: India Oral Macromolecular Formulation Market Share Analysis (%) By End User, 2021 & 2031